South Africa in HIV vaccine trial


South Africa and the United States are to start testing a new preventative HIV vaccine and have begun enrolling participants to take part in a clinical trial.

According to US state research agency the National Institutes of Health (NIH), the vaccine, called VIR-1388, is designed to help a body’s T-cells, these are part of the immune system and patrol and inspect other cells for problems.

The vaccine is intended to instruct the immune system to produce T-cells “that can recognise HIV and signal an immune response to prevent the virus from establishing chronic infection”.

The vaccine trial is funded by the NIH, the Bill and Melinda Gates Foundation and the US company Vir Biotechnology.

The study will enrol 95 HIV-negative participants at four sites in South Africa and six sites in the US.

The initial results of the vaccine trial will be announced in late 2024, but some participants will continue with the trial for three years.

In 2020, the NIH suspended the testing of another HIV vaccine in South Africa after a review found that the vaccine was ineffective in preventing HIV transmission.

Subscribe to our Youtube Channel:

Robert Ngwira
Robert Ngwira
Attended Our Future Private Secondary School in Rumphi from 2006-2009 Holder of Diploma in Journalism from Malawi Institute of Journalism (MIJ) Hobbies, reading newspapers, going out with friends, listening to radio and watching football. Email:


Please enter your comment!
Please enter your name here

Share post:

Featured Video

click to play


More like this

A Man Who Truely Loves You Will Not Last Long In Bed – Woman Claims

Ghanaian actress and nudist, Shugatiti, sparked a conversation on...

MPS tightens security in the festive season

Malawi Police Service (MPS) has disclosed plans to tighten...

TNM pumps in K5 million towards Mountain Goat Concert

Telekom Networks Malawi (TNM) has donated K15 million towards...

Grammy nomination excites Tyla

South African sensation Tyla spilled the beans on her...